Swissmedic

DHPC – Rhophylac (immunoglobulinum humanum anti-D)

Low obligation Product class Pharmaceuticals Switzerland Pharmacovigilance

14.08.2026

Dates and deadlines

Applies from

2026-08-14

Read the official source ↗

Published by Swissmedic. HealthSignal links to the original document; the summary above is extracted from the source text.